Sapiens International Corporation N.V.

Revenue in Q1 2025 was $136 million, up 1.4% from $134 million in Q1 2024; on a constant-currency basis, revenue would have been $2 million higher. Gross profit was $63 million versus $61 million last year, and gross margin improved to 46.3% from 45.4% (up 90 basis points). Operating profit was $25 million versus $24 million, operating margin was 18% versus 18.1%, net income attributable to shareholders was $21 million, and diluted EPS was $0.37 versus $0.36. ARR was $187 million, up 11.8%, recurring software/post-production revenue was $108 million, and adjusted free cash flow was $23 million versus $17 million. Cash and short-term deposits totaled $206 million and debt was $20 million as of March 31, 2025. For 2025, management raised revenue guidance to $574 million-$578 million and operating profit guidance to $94 million-$96 million; it also said Q2 operating profit should be $20 million-$21 million. Management said the revised guidance assumes foreign exchange pressure, an aggregate ~$21 million revenue impact from the Candela and Advantage Go acquisitions at the midpoint, and about a negative $5 million midpoint impact on profit, with Candela expected to turn positive in Q4 and Advantage Go expected to remain loss-making throughout the year.

Roni Al-Dor framed the quarter as evidence of solid execution, with particularly strong momentum in Life, especially North America. He emphasized that demand is building, the insurance platform is getting promising early adoption, and strategic investments in cloud, AI, and product innovation are resonating with customers. He also positioned Candela and Advantage Go as strategic moves to broaden the platform, expand geographically, and deepen offerings in APAC, London specialty, and global specialty/commercial P&C.

Roni Giladi led with the quarter’s financials: revenue of $136 million, gross margin of 46.3%, operating margin of 18%, EPS of $0.37, and adjusted free cash flow of $23 million. He highlighted the balance sheet with $206 million in cash and short-term deposits and $20 million of debt, plus a $16.8 million cash dividend and a special dividend of $0.36 per share, or $20.1 million total, approved by the board. On guidance, he raised 2025 revenue to $574 million-$578 million and operating profit to $94 million-$96 million, while noting FX tailwinds, acquisition-related revenue of about $21 million at the midpoint, and a roughly $5 million midpoint profit headwind from the two deals.

Analysts focused on the Advantage Go acquisition’s strategic fit, its impact on the model, and how it could accelerate P&C traction in North America and globally. Management said the underwriting workbench market is growing quickly, that Advantage Go opens access to the London specialty market, and that it should help cross-sell into the existing P&C base. On economics, management said Advantage Go has gross margin around 60% and ARR slightly above 50%, but is currently losing money and is expected to become profitable in 2027. Questions also focused on the life business and cloud transition; management said life momentum remains strong across North America and Europe, the life mix has risen to 26% of revenue from 23% a year ago, and nearly all new deals are on cloud while existing customers continue migrating.